who created semaglutide A new clinical trial has found that — a medication commercially known as Ozempic or Wegovy, and developed for Type 2 diabetes — may also benefit individuals with Type 1 diabetes Interview with Weight Loss Drugs

Support liver health during significant weight changes

(2024) Adipex-P highlights of prescribing information, Teva Pharmaceuticals USA (2012) Pharmacotherapy of obesity: an update on the available medications and drugs under investigation, eClinicalMedicine (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Medications for obesity management: Effectiveness and value, Journal of Managed Care & Specialty Pharmacy (2023) Comparison of continuous and intermittent anorectic therapy in obesity, The BMJ (1968) Topiramate and phentermine, StatPearls (2023) Orlistat (marketed as Alli and Xenical) information, U.S

GLP-1 medications (glucagon-like peptide 1s) are one of the most effective drug classes on the market for long-term weight loss

Journal of diabetes research, 2018, 1205121